Topic: continuous glucose monitor
Senseonics expanded its CGM distribution deal with Roche Diabetes Care to 17 additional countries, including Brazil, Russia, India and China.
Eli Lilly expanded its work with Evidation Health in developing digital biomarkers derived from smartphones, wearable sensors and voice data.
Tandem Diabetes Care launched a new predictive feature for automatically pausing insulin delivery as a free update for its CGM-enabled insulin pumps.
Senseonics’ long-term CGM is now available in clinics across the U.S. and has secured its first commercial payer.
A comparison of three continuous glucose monitoring devices found Senseonics’ recently approved Eversense implant was significantly more accurate.
Medtronic rolled out an updated meal-logging app for its iPro2 glucose-monitoring device.
The FDA cleared DreaMed’s decision support software for managing Type 1 diabetes in patients that use insulin pumps and continuous glucose monitoring.
The clearance marks the first time the FDA has signed off on such an integrated system and creates a simpler path to market for future CGMs.
The initiative will provide certain UnitedHealth members with Dexcom’s CGM technology and personalized coaching to help manage their diabetes.
Medtronic’s sales took a 4% hit in the second quarter, but the company expects growth to ramp back up in H2.